Dr. Vora’s primary research interest is in infections in immunocompromised hosts, especially viral and fungal infections in patients with primary immune deficiency, oncologic processes, and those who are recipients of immunotherapy and/or hematopoietic cell transplants. She is an investigator for the International Pediatric Fungal Network as well as the Pediatric Infectious Diseases Society’s (PIDS) Transplant Research Network and has been involved in multidisciplinary efforts to develop local and national guidance for pediatric patients with COVID-19 infections as a member of the PIDS COVID-19 Therapeutics Task Force.  Her clinical time is split between the inpatient infectious diseases service and outpatient clinic and she serves as Co-Medical Director of Oncology and Bone Marrow Transplant Infectious Diseases. In addition, she serves as a consultant to the Seattle Children’s Hospital Clinical Effectiveness (CE) Program, assisting with the development and implementation of standardized clinical pathways of care. Dr. Vora is Co-Director of the Center for Quality and Patient Safety’s Scholarship Team, which works to disseminate learnings from clinical pathways and other hospital endeavors to quality improvement literature. Dr. Vora also serves as a coach for pediatric residents.